DavidFGardinerMDFACP

PubMed

• 6 citations
  Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
  Sara Stinca, Thomas W. Barnes, Peter Vogel, Wilfried Meyers, Johannes Schulte-Pelkum, Daniel Filchtinski, Laura Steller, Thomas Hauser, Sandro Manni, David F. Gardiner...> ;Plos One. 2021 Nov 29
• 20 citations
  An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.
  Elizabeth Colston, Dennis M. Grasela, David Gardiner, R. Pat Bucy, Blisse Vakkalagadda, Alan J. Korman, Israel Lowy> ;Plos One. 2018 Jun 7
• 21 citations
  Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
  Everson, G. T., Sims, K. D., Thuluvath, P. J., Lawitz, E., Hassanein, T., Rodriguez-Torres, M., Desta, T., Hawkins, T., Levin, J. M., Hinestrosa, F., Rustgi, V., Schwa...> ;Liver international : official journal of the International Association for the Study of the Liver. 2015 Oct 17
• 35 citations
  Organic Anion Transporting Polypeptide‐Mediated Transport of, and Inhibition by, Asunaprevir, an Inhibitor of Hepatitis C Virus NS3 Protease
  Timothy Eley, Han Yh, Shu-Pang Huang, Bing He, Wenying Li, Bedford W, Michele Stonier, David F. Gardiner, K. Sims, AD Rodrigues, Richard Bertz> ;Clinical Pharmacology and Therapeutics. 2015 Feb 1
• 163 citations
  Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
  Gregory T. Everson, K. Sims, Maribel Rodriguez-Torres, Christophe Hézode, Eric Lawitz, Marc Bourlière, Véronique Loustaud-Ratti, Vinod K. Rustgi, Howard Schwartz, Harv...> ;Gastroenterology. 2014 Feb 1
• 126 citations
  Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders
  Anna S. Lok, David F. Gardiner, Christophe Hézode, Eric Lawitz, Marc Bourlière, Gregory T. Everson, Patrick Marcellin, Maribel Rodriguez-Torres, Stanislas Pol, Lawrenc...> ;Journal of Hepatology. 2014 Mar 1
• 892 citations
  Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
  Mark S. Sulkowski, David F. Gardiner, Maribel Rodriguez-Torres, K. Rajender Reddy, Tarek Hassanein, Ira M. Jacobson, Eric Lawitz, Anna S. Lok, Federico Hinestrosa, Pau...> ;The New England Journal of Medicine. 2014 Jan 15
• 188 citations
  A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepat...
  David F. Gardiner, J. Lalezari, Eric Lawitz, Michael DiMicco, Rheem Ghalib, K. Rajender Reddy, Kyong-Mi Chang, Mark S. Sulkowski, Steven O. Marro, Jeffrey Anderson, Bi...> ;Plos One. 2013 May 22
• 23 citations
  A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
  Peter Matthews, Marc Alpert, Galia Rahav, Denise Rill, Edward T. Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C. McGovern, Peter Armstrong, Charles L. B...> ;BMC Infectious Diseases. 2012 Nov 12
• 8 citations
  Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
  Julio A. Ramirez, Angel Cooper, Timothy L. Wiemken, David Gardiner, Timothy Babinchak> ;BMC Infectious Diseases. 2012 Jul 19
• 494 citations
  Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
  Anna S. Lok, David F. Gardiner, Eric Lawitz, Claudia Martorell, Gregory T. Everson, Reem Ghalib, Robert Reindollar, Vinod K. Rustgi, Fiona McPhee, Megan Wind-Rotolo, A...> ;The New England Journal of Medicine. 2012 Jan 18
• 141 citations
  In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.
  Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger, Drew Hannaman, David F. Gardiner, Daniel Dugin, Mar Boente-Carrera, Roselle Vittorino, Marina Caskey, Johanne Ander...> ;Plos One. 2011 May 16
• 22 citations
  CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cells.
  David Franco, Weimin Liu, David F. Gardiner, Beatrice H. Hahn, David D. Ho> ;Journal of Acquired Immune Deficiency Syndromes. 2011 Apr 15
• 40 citations
  Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
  Sandhya Vasan, Sarah J. Schlesinger, Zhiwei Chen, Arlene Hurley, Angela Lombardo, Soe Than, Phumla Adesanya, Catherine A. Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed,...> ;Plos One. 2010 Jan 25
• 73 citations
  Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
  David Gardiner, Gary Dukart, Angel Cooper, Timothy Babinchak> ;Clinical Infectious Diseases. 2010 Jan 15
• 59 citations
  A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A
  David F. Gardiner, Talia J. Rosenberg, Jerry Zaharatos, David Franco, David D. Ho> ;Vaccine. 2009 Jun 2
• 21 citations
  Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.
  Yaoxing Huang, Zhiwei Chen, Wenyong Zhang, Deborah Gurner, Yang Song, David F. Gardiner, David D. Ho> ;Journal of Acquired Immune Deficiency Syndromes. 2008 Apr 1
• 64 citations
  Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide
  Yaoxing Huang, Alex Chen, Xiangming Li, Zhiwei Chen, Wenyong Zhang, Yang Song, Deborah Gurner, David F. Gardiner, Sankha S. Basu, David D. Ho, Moriya Tsuji> ;Vaccine. 2008 Mar 28
• The age of veterinary specialization.
  David F. Gardiner> ;Veterinary Heritage. 2006 Nov 1
• 10 citations
  Mortality and gram-negative rod bacteraemia in the intensive care unit.
  D.F. Gardiner, S.J. Scholand, T. Babinchak> ;The Journal of Hospital Infection. 2006 Apr 1
• An unusual cause of ST segment elevation. Brugada syndrome.
  David F. Gardiner, Kyu Y. Rhee> ;Clinical Infectious Diseases. 2006 Mar 15
• 9 citations
  Multiple-site DNA vaccination enhances immune responses in mice
  David F. Gardiner, Yaoxing Huang, Sankha S. Basu, Lisa Leung, Yang Song, Zhiwei Chen, David D. Ho> ;Vaccine. 2006 Jan 16
• Canine parvovirus: from not there to everywhere: a historical look at the emergence, media coverage, and vaccine development of canine parvovirus.
  David F. Gardiner> ;Veterinary Heritage. 2005 Nov 1
• 31 citations
  Decreasing in Vitro Susceptibility of Clinical Staphylococcus aureus Isolates to Vancomycin at the New York Hospital: Quantitative Testing Redux
  Kyu Y. Rhee, David F. Gardiner, Macarthur Charles> ;Clinical Infectious Diseases. 2005 Jun 1
• 23 citations
  Clinical relevance of bacteriostatic versus bactericidal activity in the treatment of gram-positive bacterial infections.
  Kyu Y. Rhee, David F. Gardiner> ;Clinical Infectious Diseases. 2004 Sep 1
• Join now to see all